¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"RE"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
  • JrId: 5496
    JournalTitle: Repura. Leprosy.
    MedAbbr: Repura
    ISSN: 0024-1008
    ESSN:
    IsoAbbr:
    NlmId: 413731
  • JrId: 5732
    JournalTitle: revue du Corps de sante colonial.
    MedAbbr: Med Trop (Mars)
    ISSN: 0025-682X
    ESSN:
    IsoAbbr:
    NlmId: 8710146
  • JrId: 5996
    JournalTitle: A report of the ... National Forum on Hospital and Health Affairs / conducted by the Graduate Program in Hospital Administration of Duke University. National Forum on Hospital and Health Affairs.
    MedAbbr: Rep Natl Forum Hosp Health Aff
    ISSN:
    ESSN:
    IsoAbbr:
    NlmId: 100961267
  • JrId: 6760
    JournalTitle: Revue de psychiatrie de l'Universite d'Ottawa.
    MedAbbr: Psychiatr J Univ Ott
    ISSN: 0702-8466
    ESSN:
    IsoAbbr:
    NlmId: 7703518
  • JrId: 6870
    JournalTitle: Research in health economics.
    MedAbbr: Res Health Econ
    ISSN: 0197-0690
    ESSN:
    IsoAbbr:
    NlmId: 7911404
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Z61.1
    Removal from home in childhood
    ¼Ò¾Æ±â¿¡ °¡Á¤À¸·ÎºÎÅÍÀÇ °Ý¸®
  • Y83.6
    Removal of other organ)(partial, total)
    ±âŸ Àå±âÀÇ (ºÎºÐ, Àüü) ÀýÁ¦
  • Q60
    Renal agenesis and other reduction defects of kidney
    ÄáÆÏ(½ÅÀå) ¹«¹ß»ýÁõ ¹× ±âŸ °¨¼Ò¼º °á¼Õ
  • Q60.1
    Renal agenesis, bilateral
    ¾çÂʼº ÄáÆÏ(½ÅÀå) ¹«¹ß»ýÁõ
  • Q60.0
    Renal agenesis, unilateral
    ÇÑÂʼº ÄáÆÏ(½ÅÀå) ¹«¹ß»ýÁõ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • reconstructive rhinoplasty
    Àç°ÇÄÚ¼ºÇü(¼ú)
  • reconstructive surgery
    1. Àç°Ç¼ö¼ú 2. Àç°Ç¿Ü°ú
  • record
    1. ±â·Ï 2. ±â·ÏÇ¥ 3. ·¹ÄÚµå
  • record keeping
    ±â·Ïº¸°ü
  • record linkage
    ÀڷῬ°è, ±â·Ï¿¬°è
  • record management
    ±â·Ï°ü¸®
  • recorder
    ±â·Ï±â
  • recording electrode
    ±â·ÏÀü±Ø
  • recovery
    ȸº¹
  • recovery quotient
    ȸº¹Áö¼ö
  • recovery room
    ȸº¹½Ç
  • recovery time
    ȸº¹½Ã°£
  • recrement
    Àç±Í¾×
  • recrudescence
    À翬, Àç¹ß
  • recrudescent typhus
    Àç¹ß¹ßÁøÆ¼Çª½º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • refusion
    ¼øÈ¯Àç°³
  • regeneration
    Àç»ý
  • regenerative power
    Àç»ý·Â
  • region
    ºÎÀ§, ºÎ
  • regional
    ºÎÀ§-, ±¹¼Ò-, Áö¿ª-
  • regional anesthesia
    ºÎÀ§¸¶Ãë
  • regional enteritis
    ±¹¼ÒâÀÚ¿°, ±¹¼ÒÀå¿°
  • regional flap
    ±¹¼ÒÇÇÆÇ
  • registration
    ±â·Ï, µî·Ï
  • registration system
    ½Å°íÁ¦µµ, µî·ÏÁ¦µµ
  • registry
    µî·Ïü°è
  • regression
    1.ÅðÇà, 2.ȸ±Í
  • regression coefficient
    ȸ±Í°è¼ö
  • regression curve
    ȸ±Í°î¼±
  • regression line
    ȸ±Í¼±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • recognition
    ÀÎÁö, ÀνÄ, ÀçÀνÄ
  • recoil
    ¹Ýµ¿, µÇƦ
  • recoil atom
    ¹Ýµµ¿øÀÚ
  • recoil proton
    ¹Ýµµ¾çÀÚ
  • recoil wave
    ºÒ±ÔÄ¢ÆÄ
  • recollection
    Àç¼öÁý
  • recoloring
    º¹»ö
  • recombinant
    ÀçÁ¶ÇÕü, ÀçÁ¶ÇÕ±ÕÁÖ, ÀçÁ¶ÇÕÇü
  • recombinant antigen
    ÀçÁ¶ÇÕÇ׿ø
  • recombinant vaccine
    ÀçÁ¶ÇÕ¹é½Å
  • recombination
    ÀçÁ¶ÇÕ
  • recombination correction
    ÀçÁ¶ÇÕ±³Á¤
  • recombination frequency
    ÀçÁ¶ÇÕºóµµ
  • recombination rate
    Àç°áÇÕ·ü
  • recombinational repair
    ÀçÁ¶ÇÕº¹±¸
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • recessus rostralis ³ª
    ÀÔÂÊ¿À¸ñ, ÀüÇÔ¿ä(îñùèèê).
  • recessus sacciformis articulationis cubiti ³ª
    ÁÖ°üÀý³¶»óÇÔ¿ä( μï½Ò¥ßÒùèèê).
  • recessus sacciformis ³ª
    ÁָӴϸð¾ç¿À¸ñ, ³¶»óÇÔ¿ä(Ò¥ßÒùèèê).
  • recessus sacculi ³ª
    ¿øÇüÁÖ¸Ó´Ï¿À¸ñ, ±¸Çü³¶ÇÔ¿ä(Ϲû¡Ò¥ùèèê).
  • recessus sphenoethmoidalis ³ª
    Á¢Çü»ç°ñ¿À¸ñ, Á¢»çÇÔ¿ä(ïÊÞèùèèê).
  • recessus sphericus ³ª
    µÕ±Ù¿À¸ñ, ±¸Çü³¶ÇÔ¿ä(Ϲû¡Ò¥ùèèê).
  • recessus subhepatici ³ª
    °£¾Æ·¡¿À¸ñ, °£ÇÏÇÔ¿ä(ÊÜù»ùèèê).
  • recessus subphrenici ³ª
    Ⱦ°Ý¸·¾Æ·¡¿À¸ñ, Ⱦ°ÝÇÏÇÔ¿ä(üô̰ù»ùèèê).
  • recessus subpopliteus ³ª
    ¿À±Ý±Ù¾Æ·¡ÁÖ¸Ó´Ï, ½½¿Í±ÙÇÏÇÔ¿ä(ã£èÀÐÉù»ùèèê).
  • recessus triangularis ³ª
    »ï°¢¿À¸ñ, »ï°¢ÇÔ¿ä(ß²ÊÇùèèê).
  • recessus utriculi ³ª
    Ÿ¿øÁÖ¸Ó´Ï¿À¸ñ, ŸÇü³¶ÇÔ¿ä(NCû¡Ò¥ùèèê).
  • recessus vestibulo cochleare ³ª
    ÀüÁ¤´ÞÆØÀÌÇÔ¿ä, ÀüÁ¤¿Í¿ìÇÔ¿ä(îñïÔèÄéÚùè èê).
  • recessus zygomaticus ³ª
    ±Ç°ñ¿À¸ñ, Çù°ñ¿Í( ÍéèÀ).
  • recessus ³ª
    ¿À¸ñ, ÇÔ¿ä.
  • recipient
    ¼ö¿ëÀÚ, ¹Þ´ÂÀÚ, ÇÇÀü´ÞÀÚ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • receptor
    ¼ö¿ë±â
  • receptor amblyopia
    ¼ö¿ë±â¾à½Ã
  • receptor assay
    ¼ö¿ëÃ¼ÃøÁ¤
  • receptor autoradiography
    ¼ö¿ëü ÀÚ±â¹æ»ç¼±ÃÔ¿µ¼ú
  • receptor binding
    ¼ö¿ëü°áÇÕ
  • receptor blockade
    ¼ö¿ëüÂ÷´Ü
  • receptor blocking agent
    ¼ö¿ëüÂ÷´Ü<ºÀ¼â>Á¦.
  • receptor cell
    ¼ö¿ëü ¼¼Æ÷
  • receptor destroying enzyme
    ¼ö¿ëüÆÄ±«È¿¼Ò(¡­÷òÎÕý£áÈ).
  • receptor gradient
    ¼ö¿ëü°æ»ç.
  • receptor hypothesis
    ¼ö¿ëü°¡¼³
  • receptor imaging
    ¼ö¿ëü¿µ»ó(È­)
  • receptor organ
    ¼ö¿ë±â°ü(áôé»Ðïί).
  • receptor potential
    ¼ö¿ë±âÀüÀ§.
  • receptor sensitivity
    ¼ö¿ëü °¨¼ö¼º
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
  • retroperitoneal a.
    º¹¸·µÚÁ¢±Ù¹ý, Èĺ¹¸·Á¢±Ù¹ý
    ý­ÜÙØ¯ïÈÐÎÛö
  • retroperitoneal cavity
    ¹è¸·µÚ°ø°£, º¹¸·µÚ°ø°£
  • retroperitoneum
    ¹è¸·µÚ°ø°£, º¹¸·µÚ°ø°£
  • retropharyngeal
    ÀεεÚ-
  • retrosigmoid a.
    ±¸ºÒÁ¤¸Æ±¼µÚÁ¢±Ù¹ý, ÈÄSÀÚ»óÁ¢±Ù¹ý
    ý­Sí®ßÒïÈÐÎÛö
  • retrospondylolisthesis
    ôÃßµÚÀüÀ§Áõ, ÈĹæÃ´ÃßÀüÀ§Áõ
    ý­Û°ô±õÐï®êÈñø
  • retroversion
    µÚ±ÁÈû, Èı¼
    ý­ÏÝ
  • reuptake
    ÀçÈí¼ö
    î¢ýåâ¥
  • revascularization
    Ç÷°üÀçÇü¼º
    úìηî¢û¡à÷
  • reversal
    ¹ÝÀü, ¿ªÀü, ¿ª-
    Úãï®. æ½ï®, æ½-
  • reversible
    µÇ¤±â-, °¡¿ª¼º-
    ʦæ½àõ-
  • reversible r.
    °¡¿ª¹ÝÀÀ
    ʦæ½Úãëë
  • reversion
    µÇ¤±â, Àüȯ
    ï®üµ
  • Reye's s.
    ¶óÀÌ¿¡ÁõÈıº
    ¶óÀÌ¿¡ñøý¦ÏØ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • relaxation
    ÀÌ¿Ï(ì¬èÐ)
  • relaxation complex
    ÀÌ¿Ï º¹ÇÕü(ì¬èÐÜÜùêô÷)
  • relaxation effect
    ÀÌ¿Ï È¿°ú(ì¬èÐüùÍý)
  • relaxation kinetics
    ÀÌ¿Ï ¿ªµ¿ÇÐ(ì¬èÐæ³ÔÑùÊ)
  • relaxation protein
    ÀÌ¿Ï ´Ü¹éÁú(ì¬èÐÓ±ÛÜòõ)
  • relaxation technique
    ÀÌ¿Ï ¼ú(ì¬èÐâú)
  • relaxation time
    ÀÌ¿Ï ½Ã°£(ì¬èÐãÁÊà)
  • relaxed circle
    ÀÌ¿Ï ¿ø(ì¬èÐê­)
  • relaxed conformation
    ÀÌ¿Ï ÀÔüÇüÅÂ(ì¬èÐØ¡ô÷û¡÷¾)
  • relaxed control
    ÀÌ¿Ï Á¶Àý(ì¬èÐðàï½)
  • relaxed DNA
    ÀÌ¿Ï(ì¬èÐ) DNA
  • relaxed helix
    ÀÌ¿Ï ³ª¼±(ì¬èÐÕ¢àÁ)
  • relaxed muscle
    ÀÌ¿Ï ±ÙÀ°(ì¬èÐÐÉë¿)
  • relaxed plasmid
    ÀÌ¿Ï(ì¬èÐ) Çö󽺹̵å
  • relaxed strain
    ÀÌ¿Ï ±ÕÁÖ(ì¬èÐжñ»)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • renal pyramid
    ½ÅÀåÇǶó¹Ô, ½ÅÃßü
  • renal rickets
    ½Å¼º ±¸·çº´
  • renal scanning
    ½ÅÁÖ»ç¹ý
  • renal scintigraphy
    ½Å½ÃƼ±×·¡ÇÇ
  • renal transplantation
    ½ÅÀ̽Ä
  • renal tubular acidosis
    ½Å´¢¼¼°ü»êÁõ
  • renal vein
    ½ÅÁ¤¸Æ
  • renal vein thrombosis
    ½ÅÁ¤¸ÆÇ÷ÀüÁõ
  • renin
    ·¹´Ñ
  • renogram
    ·¹³ë±×·¥, ½Å±â´Éµµ
  • renovascular
    ½ÅÇ÷°ü(¼º)ÀÇ
  • renovascular hypertension
    ½ÅÇ÷°ü¼º°íÇ÷¾Ð
  • reossification
    Àç°ñÈ­
  • reparative surgery
    ±³Á¤¿Ü°ú
  • repeat
    ¹Ýº¹
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • redox
    »êÈ­ ȯ¿ø
    »óÈ£ »êÈ­, ȯ¿øÇÏ´Â È­ÇÐ °úÁ¤.
  • reducase
    ȯ¿ø È¿¼Ò
    »ý¸®ÇÐÀûÀ¸·Î ´Ù¸¸ ´ë»ç¹°ÀÇ È¯¿ø¿¡¸¸ ÀÌ¿ëµÇ´Â ¹ÝÀÀÀ» Ã˸ÅÇÏ´Â »êÈ­ ȯ¿ø È¿¼Ò Á¾·ùÀÇ ÇÑ È¿¼Ò.
  • reduced
    °¨ÅðÇÑ
    1. °ñÀýÀÇ Á¤º¹°ú °°ÀÌ ÀûÀýÇÑ À§Ä¡, ¹èÄ¡¿¡ µÇµ¹¸°. 2. ±Ý¼ÓÀÇ ÇüÀ¸·Î µÇµ¹¸°.
  • reduced dental epethelium
    ÅðÃà Ä¡»óÇÇ
  • reduced interoccusal distance
    ÀúÀ§ ±³ÇÕ
  • reducible
    ȯ¿øÇÒ ¼ö ÀÖ´Â
  • reducing agent
    ȯ¿øÁ¦, ȯ¿ø ¹°Áú
  • reducing disc displacement
    Á¤º¹¼º °üÀý ¿øÆÇ º¯À§
  • reducing flux
    ȯ¿ø À¶Á¦
  • reduction of fracture
    °ñÀý Á¤º¹
  • redundant colon
    °úÀ× °áÀå
  • Reed-sternberg cell
    ¸®µå-½ºÅϹö±× ¼¼Æ÷
    Hodgkinº´¿¡ Ư¡ÀûÀÎ Ä¿´Ù¶õ ÀÌÇü Á¶Á÷±¸ÀÌ´Ù. ÀüÇüÀûÀÎ ¼¼Æ÷´Â ´ã¿°¼ºÀÇ È£»ê¼º ¼¼Æ÷ÁúÀ» °¡Áö¸ç, 1-2°³ÀÇ ´ëÇü ÇÙ ¶Ç´Â Áö³ªÄ¡°Ô ºÐ¿±ÇÑ ÇÙÀ» °®´Â´Ù. ±× ÇÙÀº º¯¿¬ºÎ¿¡´Â ¿°»öÁúÀÇ µ¢¾î¸®¿Í ºñÁ¤»óÀûÀ¸·Î ÇöÀúÇÑ È£»ê¼ºÀÇ ÇÙ¼Òü¸¦ °¡Áö°í ÀÖ´Ù. ÀÌÇÙ¼ºÀÇ °ÍÀº °¡²û °æ»óÇüÀ» ³ªÅ¸³½´Ù.
  • reenforcement
    º¸°­, °­È­
  • refer
    Á¶È¸ÇÏ´Ù, º¸³»´Ù, ÀÇ·Ú
  • reference film
    Âü°í Çʸ§
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
receptors, cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behaviour of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology.
(12 Dec 1998)
receptors, colony-stimulating factor Cell surface receptors for colony-stimulating factors, local mediators, and hormones that regulate the survival, proliferation, and differentiation of haemopoietic cells.
(12 Dec 1998)
receptors, complement Molecules on the surface of some B-lymphocytes and macrophages, that recognise and combine with the c3b, c3d, c1q, and c4b components of complement.
(12 Dec 1998)
receptors, complement 3b Molecular sites on or in some B-lymphocytes and macrophages that recognise and combine with complement 3b. The primary structure of these receptors reveal that they contain transmembrane and cytoplasmic domains, with their extracellular portion composed entirely of thirty short consensus repeats each having 60 to 70 amino acids.
(12 Dec 1998)
receptors, complement 3d Molecular sites on or in B-lymphocytes, follicular dendritic cells, lymphoid cells, and epithelial cells that recognise and combine with complement 3d. Human cr2 serves as a receptor for both c3dg and the gp350/220 glycoprotein of herpes virus 4, human, and binds the monoclonal antibody okb7, which blocks binding of both ligands to the receptor.
(12 Dec 1998)
receptors, concanavalin a Glycoprotein moieties on the surfaces of cell membranes that bind concanavalin a selectively; the number and location of the sites depends on the type and condition of the cell.
(12 Dec 1998)
receptors, corticotropin Cell surface receptors that bind corticotropin (acth, adrenocorticotropic hormone) with high affinity and trigger intracellular changes. Pharmacology suggests there may be multiple acth receptors. An acth receptor has been cloned and belongs to a subfamily of g-protein-coupled receptors. In addition to the adrenal cortex, acth receptors are found in the brain and immune systems.
(12 Dec 1998)
receptors, corticotropin-releasing hormone Cell surface proteins that bind corticotropin-releasing hormone with high affinity and trigger intracellular changes which influence the behaviour of cells. The corticotropin releasing-hormone receptors on anterior pituitary cells mediate the stimulation of corticotropin release by hypothalamic corticotropin releasing factor. The physiological consequence of activating corticotropin-releasing hormone receptors on central neurons is not well understood.
(12 Dec 1998)
receptors, cxcr4 Seven-transmembrane G-protein-coupled receptors for alpha-chemokines. They also function as fusion cofactors for T-cell-tropic HIV-1 strains.
(12 Dec 1998)
receptors, cyclic AMP Cell surface proteins that bind cyclic AMP with high affinity and trigger intracellular changes which influence the behaviour of cells. The best characterised cyclic AMP receptors are those of the slime mold dictyostelium discoideum. The transcription regulator cyclic AMP receptor protein of prokaryotes is not included nor are the eukaryotic cytoplasmic cyclic AMP receptor proteins which are the regulatory subunits of cyclic AMP-dependent protein kinases.
(12 Dec 1998)
receptors, cytoadhesin A group of integrins that includes the platelet outer membrane glycoprotein gpiib-iiia (platelet glycoprotein gpiib-iiia complex) and the vitronectin receptor (receptors, vitronectin). They play a major role in cell adhesion and serve as receptors for fibronectin, von willebrand factor, and vitronectin.
(12 Dec 1998)
receptors, cytokine Cell surface proteins that bind cytokines and trigger intracellular changes influencing the behaviour of cells.
(12 Dec 1998)
receptors, cytoplasmic and nuclear Proteins in the cytoplasm or nucleus that specifically bind signalling molecules and trigger changes which influence the behaviour of cells. The major groups are the steroid hormone receptors, which usually are found in the cytoplasm, and the thyroid hormone receptors, which usually are found in the nucleus. Receptors, unlike enzymes, generally do not catalyze chemical changes in their ligands.
(12 Dec 1998)
receptors, dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behaviour of cells.
(12 Dec 1998)
receptors, dopamine d1 A class of dopamine receptors identified by their binding profiles for synthetic ligands, their molecular biology, and, perhaps, by their mode of action.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 12
  • Receptor, Fibroblast Growth Factor, Type 5 - »õâ The most divergent of the known fibroblast growth factor receptors. It does not contain an intracellular TYROSINE KINASE domain and has been shown to interact with FIBROBLAST GROWTH FACTOR 2. Fibroblast growth factor receptor 5 is found primarily in skeletal tissue.
    Synonyms : FGF Receptor-Like Protein, Fibroblast Growth Factor Receptor-5, Receptor 5, Fibroblast Growth Factor, Receptor, Type 5 Fibroblast Growth Factor, FGF Receptor Like Protein, Receptor-Like Protein, FGF
  • Receptor, Galanin, Type 1 - »õâ The most abundant galanin receptor subtype. It displays a high affinity for the full-length form of GALANIN.
    Synonyms : GALR1 Galanin Receptor, Galanin-1 Receptor, Galanin 1 Receptor, Galanin Receptor, GALR1, Receptor 1, Galanin, Receptor, GALR1 Galanin, Receptor, Galanin-1
  • Receptor, Galanin, Type 2 - »õâ A galanin receptor subtype with broad specificity for full length GALANIN, galanin peptide fragments and GALANIN-LIKE PEPTIDE.
    Synonyms : GALR2 Galanin Receptor, Galanin-2 Receptor, Galanin 2 Receptor, Galanin Receptor, GALR2, Receptor 2, Galanin, Receptor, GALR2 Galanin, Receptor, Galanin-2
  • Receptor, Galanin, Type 3 - »õâ A galanin receptor subtype with high affinity for GALANIN-LIKE PEPTIDE and low affinity for full length GALANIN and galanin peptide fragments.
    Synonyms : GALR3 Galanin Receptor, Galanin-3 Receptor, Galanin 3 Receptor, Galanin Receptor, GALR3, Receptor, Galanin-3
  • Receptor, IGF Type 1 - »õâ A protein-tyrosine kinase receptor that is closely related in structure to the INSULIN RECEPTOR. Although commonly referred to as the IGF-I receptor, it binds both IGF-I and IGF-II with high affinity. It is comprised of a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precusor protein. The beta subunit contains an intrinsic tyrosine kinase domain.
    Synonyms : IGF-1 Receptor, Insulin-Like-Growth Factor I Receptor, Receptor, IGF Type 1 alpha Subunit, Receptor, IGF Type 1 beta Subunit, Receptors, IGF-1, Receptors, Insulin-Like-Growth Factor I, IGF 1 Receptor, IGF I Receptor, IGF-1 Receptors, Receptor, IGF I
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 10 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÇѽŸ®ÆäÀÎݼ¿ - »õâ
Çѱ¹½Å¾à
À۾నÃÊÅÁ
ÀϹÝÀǾàǰ | ºñ±Þ¿©
·¹Å©³ëÀΰÖ0.05% - »õâ
Á߿ܽžà
Tretinoin
Àü¹®ÀǾàǰ | ¹Ì»ý»ê
¸®´ºÁ¤ - »õâ
Çѱ¹ÆÄ¸¶
A12603381 Cimicifugae Rhizoma Extract
ÀϹÝÀǾàǰ | »èÁ¦
¸®Äɾî¼ÖÁÖ250ml - »õâ
µ¿½ÅÁ¦¾à
A15106971 Aminoacetic Acid(Glycine), L-alanine, L-arginine, L-cysteine HCl, L-histidine, L-isoleucine, L-leucine, L-lysine acetate, L-methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-valine
Àü¹®ÀǾàǰ | »èÁ¦
¸®ÄÚ¸£¾× - »õâ
Áß¾ÓÁ¦¾à
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¸®¾×Ƽ¹ö¿¬Áúݼ¿ - »õâ
Áß¿Ü
Calcium pantothenate, Carduus Marianus extract, Cyanocobalamin, Nicotinamide, Pyridoxine HCl, Thiamine nitrate
ÀϹÝÀǾàǰ | ºñ±Þ¿©
·¹¿ÀÆÇ¿¬Á¶ - »õâ
»ïÀÍÁ¦¾à
¸Æ¹®µ¿ÅÁ
ÀϹÝÀǾàǰ | ºñ±Þ¿©
·¹¹ÌÆÄ¼ÖÁÖ250ml(10%) - »õâ
Á¾±Ù´ç
A01206871 Aminoacetic Acid(Glycine), L-alanine, L-arginine, L-glutamic acid, L-glutaminate-l-lysinate, L-histidine, L-isoleucine, L-leucine, L-methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-valine, N-acetyl-l-cysteine, N-acetyl-l-tyrosine
Àü¹®ÀǾàǰ | ±Þ¿©
·¹µå¼¿¿¬Áúݼ¿ - »õâ
·Ôµ¥Á¦¾à
ÀϹÝÀǾàǰ | ºñ±Þ¿©
·¹½ºÅ¥Ä°¼¿ - »õâ
µå¸²ÆÄ¸¶
A35103261 Pranoprofen
ÀϹÝÀǾàǰ | »èÁ¦
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
Restoril temazepam: a frequently prescribed benzodiazepine (trade name Restoril); takes effect slowly and lasts long enough to help those people who wake up frequently during the night
Ãâó: wordnet.princeton.edu/perl/webwn
retinoblastoma malignant ocular tumor of retinal cells; usually occurs before the third year of life; composed of primitive small round retinal cells
Ãâó: wordnet.princeton.edu/perl/webwn
reefer joint: marijuana leaves rolled into a cigarette for smoking
Ãâó: wordnet.princeton.edu/perl/webwn
reconstructive surgery plastic surgery: surgery concerned with therapeutic or cosmetic reformation of tissue
Ãâó: wordnet.princeton.edu/perl/webwn
regulator gene regulatory gene: a gene that produces a repressor substance that inhibits an operator gene
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • real-valued
    ½Ç¼öÄ¡ÀÇ;½Ç¼ö¸¦ »ç¿ëÇÑ
  • realestate
    ºÎµ¿»êÀÇ
  • realgar
    °è°ü½Ä
  • realia
    ½Ç¹°±³Àç;½ÇÀç¹°
  • realign
    ÀçÆí¼ºÇÏ´Ù;ÀçÁ¶Á¤ÇÏ´Ù;ÀçÁ¤·ÄÇÏ´Ù;~ment
  • realism
    Çö½ÇÁÖÀÇ
  • realism
    Çö½ÇÁÖÀÇ;»ç½Ç(Çö½Ç)¼º;(¹®ÇÐ.¿¹¼úµîÀÇ)»ç½ÇÁÖÀÇ;¸®¾ó¸®Áò;(Àνķп¡¼­´Â)½ÇÀç·Ð;½Ç³ä·Ð;½ÇÇÐÁÖÀÇ;½ÇüÁÖÀÇ
  • realist
    Çö½ÇÁÖÀÇÀÚ
  • realist
    Çö½ÇÁÖÀÇÀÚ;(¹®ÇÐ.¿¹¼úµîÀÇ)»ç½ÇÁÖÀÇÀÚ;¸®¾ó¸®½ºÆ®;½ÇÀç·ÐÀÚ;(½ºÄݶóöÇп¡¼­´Â)½Ç³ä·ÐÀÚ;°³³ä ½ÇÀç·ÐÀÚ;=REALISTIC
  • realistic
    Çö½ÇÀûÀÎ
  • realistic
    Çö½ÇÁÖÀÇÀÇ;Çö½ÇÀûÀÎ;½ÇÀçÀûÀÎ;»ç½ÇÆÄÀÇ;»ç½ÇÁÖÀÇÀÇ;»ç½ÇÀûÀÎ;½ÇÀç·ÐÀûÀÎ
  • realistically
    ½ÇÀç·Ð¿¡ µû¶ó;»ç½ÇÀûÀ¸·Î
  • reality
    ½ÇÀç
  • reality
    Áø½Ç(¼º);Çö½Ç;»ç½Ç;½ÇÀç;º»Ã¼(real existence);»ç½ÇÀÓ;½Ç¹°°ú ²À °°À½;¹ÚÁø¼º;(Çö»ó°èÀÇ ¹Ù´Ú¿¡ ÀÖ´Â)½ÇÀç;½Çü;½ÇÀç(°´°ü¼º)
  • reality principle
    Çö½Ç ¿øÄ¢(±Ç¸®)(ȯ°æÀÇ ºÒ°¡ÇÇÀû ¿ä±¸¿¡ µû¶ó ÀÛ¿ëÇÏ´Â ½É¸® °úÁ¤ÀÇ ¿ø¸®)
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 12
RE the act of measuring with meters or similar instruments
RE the cognitive process of understanding a written linguistic message
RE a datum about some physical state that is presented to a user by a meter or similar instrument
RE a mental representation of the meaning or significance of something
RE written material intended to be read
RE a particular interpretation or performance
RE a public instance of reciting or repeating (from memory) something prepared in advance
RE a city on the River Thames in Berkshire in southern England
RE the reading of a passage assigned by the teacher
RE a clinic for people with reading disabilities
RE desk or stand with a slanted top used to hold a text at the proper height for a lecturer
RE a lamp that provides light for reading
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 12
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á